GLA and Fabry disease: To evaluate the potential of gene therapy for FD, we generated an AAV2/8-hGLA containing a codon-optimized human GLA cDNA and liver-specific promoter and enhancer elements by a small-scale HEK293 production method, and assessed its pharmacodynamic activity in male FD mice.